loader image
Friday, December 19, 2025
77.5 F
McAllen
- Advertisement -

Heart Disease Number ONE Killer of Women

Translate to Spanish or other 102 languages!

Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer. Image for illustration purposes
Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer. Image for illustration purposes

Mega Doctor News

- Advertisement -

BTexas Tech University Health Sciences Center El Paso

Newswise — How does heart disease affect women?

Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer.

- Advertisement -

Hormonal changes that occur during menopause can bring increased cardiovascular risk in the form of higher blood pressure and cholesterol levels.

Some facts about women and heart disease:

Heart disease is the leading cause of death for women in the United States, killing 314,186 women in 2020—or about 1 in every 5 female deaths.

Heart disease is the leading cause of death for African American and white women in the United States. For Hispanic women, heart disease is second only to cancer as a cause of death.

  • About 1 in 16 women age 20 and older (6.2%) have coronary heart disease, the most common type of heart disease:
    • About 1 in 16 white women (6.1%), black women (6.5%), and Hispanic women (6%)
    • About 1 in 30 Asian women (3.2%)
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×